Clinical evaluation of oma legium (Internal) and karpogi thailam (External) for venpulli (vitiligo)in children

Clinical evaluation of oma legium (internal) and karpogi thailam (external)for venpulli (vitiligo)in children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035464

Enrollment

Registered

2021-08-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Oma legium(internal) karpogi thailam (external): Oma legium(internal) 5 to 7 years 1.3g 8 to 12 years 2.6g for 45 days Karpogi thailam (external) is applied in required amount Control I

Eligibility

Inclusion criteria

Inclusion criteria: Hypopigmented patches with hyper pigmented border without any structural changes in any part of the body except lips fingers and genital area

Exclusion criteria

Exclusion criteria: Albinism Dermatological aspect of leprosy Tinea versicolor Burn scar Post inflammatory hypopigmentation Pityriasis alba Chemical leucoderma

Design outcomes

Primary

Measure	Time frame
Efficacy of the trail drug is measured by VASI scoreTimepoint: 45 days	—

Secondary

Measure	Time frame
Improvement in the clinical symptomsTimepoint: Before and after treatment assessment	—

Countries

India

Contacts

Public ContactDr A M Amala Hazel

National institute of siddha

mmssiddha@rediffmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026